CCEL

Cryo-Cell International, Inc. CCEL

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CCEL AMS AOLS BCLI CCM ISCO JYNT MCET SNDA TOI
6M -18.50 % -15.13 % 0.00 % -8.20 % 48.51 % 26.13 % -22.50 % 0.00 % 19.88 % 111.73 %
YTD -40.04 % -26.52 % -66.67 % -67.29 % -7.44 % 53.89 % -22.72 % 900.00 % 13.07 % 1 191.75 %
1Y -26.85 % -27.90 % 0.00 % -68.04 % -15.80 % 100.00 % -23.31 % 0.00 % 12.33 % 1 099.37 %
3Y -14.40 % -12.21 % 0.00 % -98.64 % -64.67 % -60.89 % -50.46 % -90.00 % 62.30 % -19.87 %
5Y -36.78 % 19.79 % -93.75 % -99.72 % -65.69 % -74.55 % -57.85 % -95.00 % 178.17 % -63.02 %
10Y 29.40 % 23.66 % -99.96 % -98.32 % -88.27 % -96.46 % 15.31 % -96.67 % -92.47 % -60.93 %
From the beginning -11.49 % -60.00 % -100.00 % -72.34 % -92.85 % 740.00 % 22.49 % -100.00 % -89.70 % -60.93 %

Dividend

Cryo-Cell International, Inc.

American Shared Hospital Services

Concord Medical Services Holdings Limited